xRead - Nasal Obstruction (September 2024) Full Articles

15314995, 2023, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/lary.30684 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

Amer 2017 Egypt Prospective cohort study III 101 31.92 8.83 60 (59.4) Microdebrider submucosal reduction Askakal 2021 Turkey Retrospective cohort study IV 35 26.3 10.1 26 (74.3) No 80.2 23.3 21.2 4.5 Awan 2021 Pakistan Retrospective cohort study IV 60 NA 25 (41.7) No 68.45 6.97 16.98 3.82 Balsevicius 2020 Lithuania Prospective cohort study III 50 NA 31 (62) No 58.4 18.2 11.1 9.5 Bonaparte 2018 Canada Prospective cohort study III 141 41.3 13.4 101 (71.6) Radiofrequency 66.5 20.3 20.5 23 Cantone 2018 Italy Prospective cohort study III 494 39.6 3.2 210 (42.5) No 49.60 20 24.06 19 D ą browska Bie n 2021 Poland Prospective cohort study III 27 34.67 11.95 21 (77.8) No 60.3 20.4 32.9 16.8 39.6 33.2 Dagistan 2021 Turkey Prospective cohort study III 40 29.6 9.3 25 (62.5) Various techniques 91.1 6.4 10.0 4.1 Garzaro 2019 Italy Prospective cohort study III 276 NA 173 (62.7) Various techniques 72.7 11.35 24.85 8.85 Ghosh 2021 India Prospective cohort study III 80 NA 47 (58.8) No 56.7 9.05 14.5 5.45 3.9 3.95 Gillman 2019 USA Prospective cohort study III 60 NA 44 (73.3) Not speci fi ed 74.25 14.7 16.3 14.5 16 12.9 Hsu, H.C 2017 Taiwan Retrospective cohort study IV 50 NA 26 (52) Not speci fi ed 67 14.3 15.4 14.7 15.7 16.4 16.9 19.3 Kahveci 2012 Turkey Prospective cohort study III 27 NA 22 (81.5) No 60.2 17.45 11.28 10.45 Karahatay 2016 Turkey Prospective cohort study III 83 27.5 6.2 76 (91.6) Not speci fi ed 72.62 16.42 10.97 10.75 Kim 2017 South Korea Retrospective cohort study IV 141 32.8 12.9 117 (83) Radiofrequency 70.5 26.7 28.7 22 Kumar 2015 India Prospective cohort study III 30 NA NA Various techniques 70.75 11.6 10.08 12.5 9.5 12.1 Lachanas 2014 Greece Prospective cohort study III 50 NA 33 (66) Various techniques 74.2 18.58 12 19.92 Larrosa 2014 Spain Prospective cohort study III 58 NA 36 (62) No 63.4 19.3 14.0 17.3 Law 2020 USA Retrospective cohort study IV 98 42.5 16.6 56 (57.1) Radiofrequency 72.1 19.0 12.0 14.6 Mehel 2020 Turkey Retrospective cohort study IV 65 27.68 10.14 48 (73.8) Diathermy 53 15.6 5.7 6.5 Mondina 2012 France Prospective cohort study III 100 NA 64 (64) Various techniques 57.9 25 22.7 24.1 Seden 2022 Turkey Randomized controlled cohort study II 74 35.35 12.28 50 (67.6) Not speci fi ed 67.35 22.4 26.9 26.85 Ş im Ş ek 2014 Turkey Retrospective cohort study III 32 32 10.1 24 (75) Not speci fi ed 53.4 14.5 26.0 17.8 Stewart 2004 USA Prospective cohort study III 59 NA 38 (64.4) Not speci fi ed 67.5 19.5 23.1 19.5 26.6 23.8 Taylan 2021 Turkey Prospective cohort study III 65 32.31 10.91 25 (38.5) Submucous inferior turbinoplasty 15.7 3.13 4.15 1.95 Valsamidis 2019 Greece Prospective cohort study III 60 32.98 11.98 34 (56.7) Microdebrider submucosal reduction 76.1 20 27.73 27.05 Valsamidis 2018 Greece Prospective cohort study III 40 NA 25 (62.5) Microdebrider submucosal reduction 79.12 15.05 8.87 8.35 Yazici 2015 Turkey Prospective cohort study III 181 NA 127 (70.2) No 62.5 20.95 23 22.4 80.95 14.5 11.2 8.5

NOSE

12months

NOSE

6-months

NOSE

3-months

NOSE

Baseline

Males (%) Inferior Turbinoplasty

No. of

Included Studies ’ General Characteristics. No. of Age (Mean SD)

TABLE I.

Patients

Level of

Evidence

Author Year Country Study Design

Abbreviations: NA, not assessable; SD, standard deviation.

Laryngoscope 133: December 2023

Alessandri-Bonetti et al.: NOSE Score After Septoplasty

3240